Get notified when ZWS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsZurn Elkay reports 10% Q2 sales growth, raises full-year outlook on margin expansion
Filed July 28, 2026 · Period ending July 28, 2026 · ~1 min read
Key Changes
-
high
Q2 net sales rose 10% to $491M with adjusted EBITDA margin expanding 120 bps to 27.7%; adjusted EPS increased 19% to $0.50, reflecting pricing realization and productivity gains.
Exhibit 99.1 view on EDGAR → -
high
Received $48M cash refund for previously paid IEEPA reciprocal tariffs, boosting GAAP operating income by $47.6M (excluded from adjusted EBITDA); one-time benefit elevated reported earnings.
Exhibit 99.1 view on EDGAR → -
high
Raised full-year 2026 adjusted EBITDA guidance to $503-513M (140 bps margin expansion vs. 2025, excluding tariff refunds) and free cash flow to at least $350M; Q3 core sales growth expected 6-7%.
Exhibit 99.1 view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IMMR 10-K) is open in full — no account needed.
Partner
Trade ZWS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 29, 2026 · How we verify